Variables | Frequency | Percent (%) | |
---|---|---|---|
MS status | No MS | 109 | 27.1 |
Mild | 51 | 12.7 | |
Moderate | 92 | 22.9 | |
Sever | 150 | 37.3 | |
MR status | No MR | 91 | 22.6 |
Mild | 105 | 26.1 | |
Moderate | 152 | 37.8 | |
Sever | 54 | 13.4 | |
AR status | No AR | 208 | 51.5 |
Mild | 94 | 23.4 | |
Moderate | 78 | 19.4 | |
Sever | 22 | 5.5 | |
TR status | No TR | 131 | 32.6 |
Mild | 59 | 14.7 | |
Moderate | 109 | 27.1 | |
Sever | 103 | 25.6 | |
NYHA functional class | No heart failure | 131 | 32.6 |
Class I | 30 | 7.5 | |
Class II | 59 | 14.7 | |
Class III | 95 | 23.6 | |
Class IV | 87 | 21.6 | |
DM | Yes | 32 | 8 |
No | 370 | 92 | |
Ischemic heart disease | Yes | 59 | 14.7 |
No | 343 | 85.2 | |
Dyslipidemia | Yes | 42 | 10.4 |
No | 360 | 89.6 | |
Hyperthyroidism | Yes | 30 | 7.5 |
No | 372 | 92.5 | |
Benzanthin penicillin | Yes | 343 | 85.3 |
No | 59 | 14.7 | |
Diuretics | Yes | 305 | 75.9 |
No | 97 | 24.1 | |
Beta blockers | Yes | 271 | 67.4 |
No | 131 | 32.6 | |
Warfarin | Yes | 206 | 51.2 |
No | 196 | 48.8 | |
Angiotensin-converting enzyme inhibitors | Yes | 175 | 43.5 |
No | 227 | 56.5 | |
Digoxin | Yes | 135 | 33.6 |
No | 267 | 66.4 | |
Aspirin | Yes | 76 | 18.9 |
No | 326 | 81.1 |